4
Changes in Ownership
X4 Pharmaceuticals, Inc Filed Acc 0001628280-24-042542
Chief Operating Officer sold 67,695 shares at $0.57 ($38,329)
- Chief Operating Officer acquired 230,645 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| DiBiase Mary Chief Operating Officer | 2024-10-04 | Grant or award | +230,645 | 519,755 | D | ||
| DiBiase Mary Chief Operating Officer | 2024-10-07 | Sale | −67,695 | $0.57 | $38,329 | 452,060 | D |
| Open-market sales · 67,695 sh · avg $0.57 · $38,329 | |||||||
Loading xslF345X05/wk-form4_1728420247.xml…